Search Results - "Vallard, A."

Refine Results
  1. 1

    Biomarkers of resistance to radiation therapy: a prospective study in cervical carcinoma by Moreno-Acosta, P, Vallard, A, Carrillo, S, Gamboa, O, Romero-Rojas, A, Molano, M, Acosta, J, Mayorga, D, Rancoule, C, Garcia, M A, Cotes Mestre, M, Magné, N

    Published in Radiation oncology (London, England) (17-07-2017)
    “…Clinical parameters and proteins have recently been suggested as possible causes of radiotherapy (RT) resistance in cervical carcinoma (CC). The objective of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Navigating the highlights of phase III trials: a watchful eye on evidence-based radiotherapy by Trone, J.C., Espenel, S., Rehailia-Blanchard, A., Guillaume, E., Vial, N., Rancoule, C., Rodriguez-Lafrasse, C., Ben Mrad, M., El Meddeb Hamrouni, A., Ollier, E., Chargari, C., Deutsch, E., Vallard, A., Magné, N.

    Published in Annals of oncology (01-11-2017)
    “…Phase III randomized controlled trials (RCTs) are the cornerstone of evidence-based oncology. However, there is no exhaustive review describing the…”
    Get full text
    Journal Article
  6. 6

    Pharmacological modulation of radiation-induced oral mucosal complications by Bockel, S., Vallard, A., Lévy, A., François, S., Bourdis, M., Le Gallic, C., Riccobono, D., Annede, P., Drouet, M., Tao, Y., Blanchard, P., Deutsch, É., Magné, N., Chargari, C.

    Published in Cancer radiothérapie (01-09-2018)
    “…Radiation-induced mucositis is a common toxicity, especially in patients with head and neck cancers. Despite recent technological advances in radiation…”
    Get full text
    Journal Article
  7. 7

    Five-fraction HDR brachytherapy in locally advanced cervical cancer: A monocentric experience by Ogorodniitchouk, O., Aunier, J., Bousarsar, A., Lahmamssi, C., Sotton, S., Ouaz, H., Moreno-Acosta, P., Moslemi, D., Molekzadehmoghani, M., Langrand-Escure, J., Magne, N., Vallard, A.

    Published in Cancer radiothérapie (01-07-2021)
    “…The 5-fraction scheme (5×5–5.5Gy) is a common High-Dose Rate (HDR) intracavitary brachytherapy regimen for locally advanced cervical cancer (LACC). Yet, its…”
    Get full text
    Journal Article
  8. 8

    Physiopathology and pharmacological perspectives in the treatment of radiation enteritis by Rehailia-Blanchard, A, He, M Y, Rancoule, C, Vallard, A, Espenel, S, Nivet, A, Magné, N, Chargari, C

    Published in Cancer radiothérapie (01-06-2019)
    “…The small intestine is an organ frequently exposed in abdominal and pelvic irradiations. Acute and late toxicity can sometimes be difficult to manage and can…”
    Get full text
    Journal Article
  9. 9
  10. 10

    The Role of Gnrh Analogues in 36-Month Disease-Free Survival in Non-Menopausal Patients with Hormone Receptor-Positive Breast Cancer by S Akbarzadeh Pasha, A Gholizadeh Pasha, M Raanaee, A Moghadamnia, A Vallard, D Moslemi

    “…BACKGROUND AND OBJECTIVE: The effectiveness of ovarian function suppression therapies in patients with non-menopausal breast cancer has not yet been…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Use of 4D-CT for radiotherapy planning and reality in France: Data from a national survey by De Oliveira Duarte, S., Rancoule, C., He, M.Y., Baury, M., Sotton, S., Vallard, A., Espenel, S., Guy, J.-B., Guillaume, É., Vial, N., Magné, N., Rehailia-Blanchard, A.

    Published in Cancer radiothérapie (01-09-2019)
    “…Lung and some digestive tumours move during a respiratory cycle. Four-dimensional scanography (4D-CT) is commonly used in treatment planning to account for…”
    Get full text
    Journal Article
  13. 13

    Treatment de-intensification strategies for HPV-driven oropharyngeal cancer: A short review by Lahmamssi, C, Guy, J-B, Benchekroun, N, Bouchbika, Z, Taoufik, N, Jouhadi, H, Sahraoui, S, Benider, A, Ben Mrad, M, Jmour, O, Bousarsar, A, Lan, M L, Lei, Q, Benna, M, Moslemi, D, Vallard, A, Magné, N

    Published in Cancer radiothérapie (01-06-2020)
    “…The incidence of oropharyngeal cancer induced by human papillomavirus (HPV) infection is steadily increasing in developed countries. These tumors are more…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Predictors of asthenia in breast and prostate cancer patients undergoing curative radiotherapy by Guillaume, E, Daguenet, E, Lahmamssi, C, Ben Mrad, M, Jmour, O, Langrand-Escure, J, Rehailia-Blanchard, A, Vial, N, Pigné, G, Bard-Reboul, S, Maison, M, Tinquaut, F, Vallard, A, Magné, N

    Published in Cancer radiothérapie (01-02-2020)
    “…Patients frequently report asthenia during radiation. The present study aimed at identifying the correlation between numerous clinical and tumoral factors and…”
    Get full text
    Journal Article
  16. 16

    Rare histologic types of rectal cancer: A monocentric cases series report by Vallard, A., Diao, P., Garcia, M.-A., Pigné, G., Vial, N., Forest, F., Peoc’h, M., Langrand-Escure, J., Magné, N.

    Published in Cancer radiothérapie (01-02-2019)
    “…There is paucity of data on rectal cancer with uncommon histologic types. The objective was to describe managements of care and outcomes in patients with…”
    Get full text
    Journal Article
  17. 17

    Medical prevention and treatment of radiation-induced pulmonary complications by Vallard, A, Rancoule, C, Le Floch, H, Guy, J-B, Espenel, S, Le Péchoux, C, Deutsch, É, Magné, N, Chargari, C

    Published in Cancer radiothérapie (01-08-2017)
    “…Radiation-induced lung injuries mainly include the (acute or sub-acute) radiation pneumonitis, the lung fibrosis and the bronchiolitis obliterans organizing…”
    Get full text
    Journal Article
  18. 18

    Outcomes and treatments of IB1 cervical cancers with high recurrence risk: A 13 years’ experience by Espenel, S., Garcia, M.-A., Vallard, A., Langrand-Escure, J., Guy, J.-B., Trone, J.-C., Ben Mrad, M., Chauleur, C., de Laroche, G., Moreno-Acosta, P., Rancoule, C., Magné, N.

    Published in Cancer radiothérapie (01-12-2018)
    “…The aim of the present study was to identify management strategies and outcomes of patients with stage IB1 cervical cancer with high recurrence risk. Medical…”
    Get full text
    Journal Article
  19. 19

    HPV-16 variants’ impact on uterine cervical cancer response to radiotherapy: A descriptive pilot study by Moreno-Acosta, P., Vallard, A., Molano, M., Huertas, A., Gamboa, Ó., Cotes, M., Romero-Rojas, A., Rancoule, C., Magné, N.

    Published in Cancer radiothérapie (01-04-2017)
    “…Although the large impact of Human papilloma virus (HPV) in cervical cancer is established, its place as a therapeutic target is new and according to the…”
    Get full text
    Journal Article
  20. 20

    Real-life efficacy of volumetric modulated arc therapy in head and neck squamous cell carcinoma by Moncharmont, C, Vallard, A, Guy, J.-B, Prades, J.-M, Rancoule, C, Magné, N

    “…Abstract Objectives There is paucity of data on the efficacy of volumetric modulated arc therapy (VMAT) in head and neck squamous cell carcinoma (HNSCC). The…”
    Get full text
    Journal Article